These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 16940143)
1. The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration. d'Empaire G; Baer MT; Gibson FC Infect Immun; 2006 Nov; 74(11):6236-43. PubMed ID: 16940143 [TBL] [Abstract][Full Text] [Related]
2. Differential cytokine expression by human dendritic cells in response to different Porphyromonas gingivalis capsular serotypes. Vernal R; León R; Silva A; van Winkelhoff AJ; Garcia-Sanz JA; Sanz M J Clin Periodontol; 2009 Oct; 36(10):823-9. PubMed ID: 19682172 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the capsular polysaccharide biosynthesis locus of Porphyromonas gingivalis and development of a K1-specific polymerase chain reaction-based serotyping assay. Brunner J; Crielaard W; van Winkelhoff AJ J Periodontal Res; 2008 Dec; 43(6):698-705. PubMed ID: 18624945 [TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens. Sims TJ; Schifferle RE; Ali RW; Skaug N; Page RC Oral Microbiol Immunol; 2001 Aug; 16(4):193-201. PubMed ID: 11442843 [TBL] [Abstract][Full Text] [Related]
5. Distinct human T-lymphocyte responses triggered by Porphyromonas gingivalis capsular serotypes. Vernal R; Diaz-Guerra E; Silva A; Sanz M; Garcia-Sanz JA J Clin Periodontol; 2014 Jan; 41(1):19-30. PubMed ID: 24117627 [TBL] [Abstract][Full Text] [Related]
6. Enhanced monocyte migration and pro-inflammatory cytokine production by Porphyromonas gingivalis infection. Pollreisz A; Huang Y; Roth GA; Cheng B; Kebschull M; Papapanou PN; Schmidt AM; Lalla E J Periodontal Res; 2010 Apr; 45(2):239-45. PubMed ID: 19778327 [TBL] [Abstract][Full Text] [Related]
7. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Gonzalez D; Tzianabos AO; Genco CA; Gibson FC Infect Immun; 2003 Apr; 71(4):2283-7. PubMed ID: 12654858 [TBL] [Abstract][Full Text] [Related]
8. Novel polysaccharide capsular serotypes in Porphyromonas gingivalis. Laine ML; Appelmelk BJ; van Winkelhoff AJ J Periodontal Res; 1996 May; 31(4):278-84. PubMed ID: 8814599 [TBL] [Abstract][Full Text] [Related]
9. The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts. Brunner J; Scheres N; El Idrissi NB; Deng DM; Laine ML; van Winkelhoff AJ; Crielaard W BMC Microbiol; 2010 Jan; 10():5. PubMed ID: 20064245 [TBL] [Abstract][Full Text] [Related]
10. Virulence of six capsular serotypes of Porphyromonas gingivalis in a mouse model. Laine ML; van Winkelhoff AJ Oral Microbiol Immunol; 1998 Oct; 13(5):322-5. PubMed ID: 9807125 [TBL] [Abstract][Full Text] [Related]
11. Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone-derived cells. Jiang Y; Graves DT J Periodontol; 1999 Dec; 70(12):1472-8. PubMed ID: 10632523 [TBL] [Abstract][Full Text] [Related]
12. Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis. Califano JV; Schifferle RE; Gunsolley JC; Best AM; Schenkein HA; Tew JG J Periodontol; 1999 Jul; 70(7):730-5. PubMed ID: 10440633 [TBL] [Abstract][Full Text] [Related]
13. Variability of the dendritic cell response triggered by different serotypes of Aggregatibacter actinomycetemcomitans or Porphyromonas gingivalis is toll-like receptor 2 (TLR2) or TLR4 dependent. Díaz-Zúñiga J; Monasterio G; Alvarez C; Melgar-Rodríguez S; Benítez A; Ciuchi P; García M; Arias J; Sanz M; Vernal R J Periodontol; 2015 Jan; 86(1):108-19. PubMed ID: 25224175 [TBL] [Abstract][Full Text] [Related]
14. Activation of RANKL-induced osteoclasts and memory T lymphocytes by Porphyromonas gingivalis is serotype dependant. Vernal R; Díaz-Zúñiga J; Melgar-Rodríguez S; Pujol M; Diaz-Guerra E; Silva A; Sanz M; Garcia-Sanz JA J Clin Periodontol; 2014 May; 41(5):451-9. PubMed ID: 24476556 [TBL] [Abstract][Full Text] [Related]
15. The capsule of Porphyromonas gingivalis leads to a reduction in the host inflammatory response, evasion of phagocytosis, and increase in virulence. Singh A; Wyant T; Anaya-Bergman C; Aduse-Opoku J; Brunner J; Laine ML; Curtis MA; Lewis JP Infect Immun; 2011 Nov; 79(11):4533-42. PubMed ID: 21911459 [TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from Goyette-Desjardins G; Auger JP; Dolbec D; Vinogradov E; Okura M; Takamatsu D; Van Calsteren MR; Gottschalk M; Segura M Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747605 [No Abstract] [Full Text] [Related]
17. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. Kopydlowski KM; Salkowski CA; Cody MJ; van Rooijen N; Major J; Hamilton TA; Vogel SN J Immunol; 1999 Aug; 163(3):1537-44. PubMed ID: 10415057 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and distribution of six capsular serotypes of Porphyromonas gingivalis in periodontitis patients. Laine ML; Appelmelk BJ; van Winkelhoff AJ J Dent Res; 1997 Dec; 76(12):1840-4. PubMed ID: 9390477 [TBL] [Abstract][Full Text] [Related]
19. Identification of the genes associated with a virulent strain of Porphyromonas gingivalis using the subtractive hybridization technique. Tachibana-Ono M; Yoshida A; Kataoka S; Ansai T; Shintani Y; Takahashi Y; Toyoshima K; Takehara T Oral Microbiol Immunol; 2008 Feb; 23(1):84-7. PubMed ID: 18173803 [TBL] [Abstract][Full Text] [Related]